Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Case Reports
. 2020 Dec;27(12):2651-2657.
doi: 10.1111/ene.14478. Epub 2020 Sep 22.

COVID-19-related encephalopathy: a case series with brain FDG-positron-emission tomography/computed tomography findings

Affiliations
Case Reports

COVID-19-related encephalopathy: a case series with brain FDG-positron-emission tomography/computed tomography findings

C Delorme et al. Eur J Neurol. 2020 Dec.

Abstract

Aim: The aim of this paper is to describe the clinical features of COVID-19-related encephalopathy and their metabolic correlates using brain 2-desoxy-2-fluoro-D-glucose (FDG)-positron-emission tomography (PET)/computed tomography (CT) imaging.

Background and purpose: A variety of neurological manifestations have been reported in association with COVID-19. COVID-19-related encephalopathy has seldom been reported and studied.

Methods: We report four cases of COVID-19-related encephalopathy. The diagnosis was made in patients with confirmed COVID-19 who presented with new-onset cognitive disturbances, central focal neurological signs, or seizures. All patients underwent cognitive screening, brain magnetic resonance imaging (MRI), lumbar puncture, and brain 2-desoxy-2-fluoro-D-glucose (FDG)-positron-emission tomography (PET)/computed tomography (CT) (FDG-PET/CT).

Results: The four patients were aged 60 years or older, and presented with various degrees of cognitive impairment, with predominant frontal lobe impairment. Two patients presented with cerebellar syndrome, one patient had myoclonus, one had psychiatric manifestations, and one had status epilepticus. The delay between first COVID-19 symptoms and onset of neurological symptoms was between 0 and 12 days. None of the patients had MRI features of encephalitis nor significant cerebrospinal fluid (CSF) abnormalities. SARS-CoV-2 RT-PCR in the CSF was negative for all patients. All patients presented with a consistent brain FDG-PET/CT pattern of abnormalities, namely frontal hypometabolism and cerebellar hypermetabolism. All patients improved after immunotherapy.

Conclusions: Despite varied clinical presentations, all patients presented with a consistent FDG-PET pattern, which may reflect an immune mechanism.

Keywords: COVID-19; FDG-PET/CT; SARS-CoV-2; encephalitis; encephalopathy.

PubMed Disclaimer

Conflict of interest statement

Vincent Navarro has served as a board member for UCB Pharma, LivaNova, GW Pharma and EISAI.

Figures

Figure 1
Figure 1
Brain FDG‐postitron‐emission tomography/computed tomography imaging in four patients with COVID‐19 and acute cognitive impairment.

References

    1. Mao L, Jin H, Wang M, et al. Neurologic manifestations of hospitalized patients with coronavirus disease 2019 in Wuhan, China. JAMA Neurol 2020; 77: 683. - PMC - PubMed
    1. Helms J, Kremer S, Merdji H, et al. Neurologic features in severe SARS‐CoV‐2 infection. N Engl J Med 2020; 382: 2268–2270. - PMC - PubMed
    1. Poyiadji N, Shahin G, Noujaim D, Stone M, Patel S, Griffith B. COVID‐19‐associated acute hemorrhagic necrotizing encephalopathy: CT and MRI features. Radiology 2020; 296: 119. - PMC - PubMed
    1. Moriguchi T, Harii N, Goto J, et al. A first case of meningitis/encephalitis associated with SARS‐Coronavirus‐2. Int J Infect Dis 2020; 94: 55–58. - PMC - PubMed
    1. Bernard‐Valnet R, Pizzarotti B, Anichini A, et al. Two patients with acute meningo‐encephalitis concomitant to SARS‐CoV‐2 infection. Eur J Neurol 2020; 7: e43–e44. - PMC - PubMed

Publication types

MeSH terms

Substances